NSB is probably one of the most undervalued stocks atm, as they were unfortunate to report their positive data at the worst possible time. Although there are a lot of investors on the sideline for NSB waiting for them to complete pre-clinical tox and move into Phase 1. Main value inflection would be at that time.
But lets not talk about NSB here, we are here to see progress with IXC. Hopefully that placement overhang will be removed today tomorrow and the share price will catch up.
IXC Price at posting:
$1.43 Sentiment: Buy Disclosure: Held
